{"nct_id":"NCT02116803","title":"An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored Single Agent Dovitinib Studies Which Fulfilled the Requirements for the Primary Objective","status":"COMPLETED","status_verified_date":"2018-01","start_date":"2014-05-28","start_date_type":"ACTUAL","primary_completion_date":"2016-11-28","primary_completion_date_type":"ACTUAL","completion_date":"2016-11-28","completion_date_type":"ACTUAL","phases":["PHASE2","PHASE3"],"tickers":["NVS"]}